Soleno Therapeutics Faces Class Action Over Safety Risks in Lead Drug DCCR
Portnoy Law Firm launches class action lawsuit against $SLNO alleging concealment of safety issues in lead drug DCCR, following 27% stock plunge.
SLNOsecurities fraudclass action lawsuit